Dr Gelareh Eslamian

I acquired my medical degree from Babol University in Iran; continued my foundation years and medical training in the Peninsula deanery, Devon and completed my medical oncology training in Wessex, South Yorkshire (Weston Park Hospital), London (Guys and St Thomas' and St George's hospitals) and Kent deaneries.

I specialise in treatment of breast, oesophagus, gastric and pancreato-biliary cancers with a main focus and passion on treating breast cancer. I would encourage active participation in clinical trials and aim to provide the latest available cancer treatment to my patients. I have extensive experience in systemic anti-cancer therapies including chemotherapy, immunotherapy, monoclonal antibodies and endocrine treatments.

I am a core member of the Windsor Breast Multi-Disciplinary Team and the Royal Berkshire UGI MDT. I have extensive experience in treating acutely unwell cancer patients and have a dedicated weekly ward (Acute Oncology). I am the chemotherapy lead for Berkshire Cancer Centre and Chair of the Chemotherapy Steering Group.

I am also interested in medical education and am a clinical supervisor for medical trainees.

I have been a co-investigator in numerous oncology phase 3 clinical trials and the following breast cancer trials ARTemis, EMILIA, AZURE, D-CARE, MANTA, OLYMPIA, PERESHONE, ROSCO and PALOMA-2.

Dissertation for final year of MD, a research project with “Effects of soy protein on serum hyperlipidaemia”.  It was a non-randomised clinical trial study on 98 patients; they were divided in two groups: case (diet+soy) and control (diet).  I scored distinction on this research project.